Advertisement

Digestive Diseases and Sciences

, Volume 39, Issue 7, pp 1569–1575 | Cite as

Effect of anti-allergic agents on chemotaxis of neutrophils by stimulation of chemotactic factor released from hepatocytes exposed to ethanol

  • Yasushi Shiratori
  • Hiroshi Takada
  • Kenji Hai
  • Hiroki Kiriyama
  • Emmanuel Mawet
  • Yutaka Komatsu
  • Yasuro Niwa
  • Masayuki Matsumura
  • Shuichiro Shiina
  • Tateo Kawase
  • Kazunori Matsumoto
  • Kazuo Kamii
  • Masao Omata
  • Mitsugu Tanaka
Original Articles

Abstract

In an attempt to clarify a mechanism of neutrophil infiltration in the liver of alcoholics and possible therapeutic effect of antiallergic agents on accumulation of these cells in the liver, we investigated chemotaxis of neutrophils by stimulation of a chemotactic factor released from rat hepatocytes exposed to ethanol. When hepatocytes were incubated with more than 30 mM ethanol for 24 hr, chemotactic activity for both rat and human neutrophils was demonstrated in the conditioned medium. An enhanced chemotactic activity of the conditioned medium was reduced in the presence of antibody against KC/gro protein, one of the interleukin-8-related cytokines in rodents. Antiallergic agents such as azelastine or ketotifen at a concentration of >0.01 µM markedly reduced chemotaxis of neutrophils. Prednisolone at a concentration of >10 µM also reduced chemotaxis of neutrophils. These results suggest that neutrophil accumulation in the liver of human alcoholics could be induced by a chemotactic factor produced by the ethanol-treated hepatocytes and that antiallergic agents could be effective against the extent of alcoholic hepatitis by reducing chemotaxis of neutrophils.

Key words

ethanol hepatocytes chemotactic factor neutrophils antiallergic agents prednisolone 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    An international group: Alcoholic liver disease: Morphological manifestations. Lancet 1:707–711, 1981Google Scholar
  2. 2.
    Takahashi T, Kamimura T, Ichida F: Ultrastructural findings on polymorphonuclear leucocyte infiltration and acute hepatocellular damage in alcoholic hepatitis. Liver 7:347–358, 1987Google Scholar
  3. 3.
    Sabesin S: Alcoholic hepatitis. Gastroenterology 74:276–286, 1978Google Scholar
  4. 4.
    French SW, Burbige EJ: Alcoholic hepatitis: Clinical, morphologic, pathogenic, and therapeutic aspects.In Progress in Liver Diseases, vol VI. H Popper, F Schaffner (eds). New York, Grune and Stratton, 1979, pp 557–579Google Scholar
  5. 5.
    Snyderman R, Mergenhagen SE: Chemotaxis of macrophages.In Immunobiology of the Macrophages. DS Nelson (ed). New York, Academic press, 1976, pp 323–348Google Scholar
  6. 6.
    Perez HD, Roll FJ, Bissell DM, Shak S, Goldstein IM: Production of chemotactic activity for polymorphonuclear leukocytes by cultured rat hepatocytes exposed to ethanol. J Clin Invest 74:1350–1357, 1984Google Scholar
  7. 7.
    Roll FJ, Bissell DM, Perez HD: Human hepatocytes metabolizing ethanol generate a non-polar chemotactic factor for human neutrophils. Biochem Biophys Res Commun 137:688–694, 1986Google Scholar
  8. 8.
    Shiratori Y, Takada H, Hai K, Kiriyama H, Nagura T, Tanaka M, Matsumoto K, Kamii K: Generation of chemotactic factor by hepatocytes isolated from chronically ethanol-fed rats. Dig Dis Sci 37:650–658, 1992Google Scholar
  9. 9.
    Shiratori Y, Takada H, Hikiba Y, Okano K, Nagura T, Matsumura M, Komatsu Y, Kato N, Tada M, Niwa Y, Omata M: Novel mechanism of neutrophil accumulation in the liver of alcoholics. Hepatology 18:123A, 1993Google Scholar
  10. 10.
    Ferluga J, Allison AC: Role of mononuclear infiltrating cells in pathogenesis of hepatitis. Lancet 2:610–611, 1978Google Scholar
  11. 11.
    Shiratori Y, Tanaka M, Hai K, Kawase T, Shiina S, Sugimoto T: Role of endotoxin-responsive macrophages in hepatic injury. Hepatology 11:183–192, 1990Google Scholar
  12. 12.
    Keppler D, Hagmann W, Rapp S, Denzlinger C, Koch HK: The relation of leukotrienes to liver injury. Hepatology 5:883–891, 1985Google Scholar
  13. 13.
    Tiegs G, Wendel A: Leukotriene-mediated liver injury. Biochem Pharmacol 37:2569–2573, 1988Google Scholar
  14. 14.
    Shiratori Y, Tanaka M, Umihara J, Kawase T, Shiina S, Sugimoto T: Leukotriene inhibitors modulate hepatic injury induced by lipopolysaccharide-activated macrophages. J Hepatol 10:51–61, 1990Google Scholar
  15. 15.
    Maddrey WC, Boitnott JK, Bedine MS, Weber FL, Mezey E, White RI: Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 75:193–199, 1978Google Scholar
  16. 16.
    Maddrey WC, Carithers RL, Herlong HF, Combes B, Diehl AM, Shaw E, Fallon HJ: Prednisolone therapy in patients with severe alcoholic hepatitis: Results of a multi-center trial. Hepatology 6:1202, 1986Google Scholar
  17. 17.
    Seglen PO: Preparation of rat liver cells. III. Enzymatic requirements for tissue dispersion. Exp Cell Res 82:391–398, 1973Google Scholar
  18. 18.
    Chodirker WB, Bock GN, Vaughan JH: Isolation of human PMN leukocytes and granules. Observation on early blood dilution and on heparin. J Lab Clin Med 71:9–16, 1968Google Scholar
  19. 19.
    Ferrante A, Thong YH: A rapid one-step procedure for purification of mononuclear and polymorphonuclear leukocytes from human blood using a modification of the Hypaque-Ficoll technique. J Immunol Methods 24:389–393, 1978Google Scholar
  20. 20.
    Onozaki K, Ichikawa M, Hashimoto T: A simplified assay for neutrophil chemotactic activity of lymphocyte culture supernatants. Jpn J Exp Med 49:281–287, 1979Google Scholar
  21. 21.
    Keller HU, Sorkin E: Studies on chemotaxis. IV. The influence on serum factors on granulocyte locomotion. Immunology 10:409–416, 1966Google Scholar
  22. 22.
    Katayama S, Tsunoda H, Sakuma Y, Kai H, Tanaka I, Katayama K: Effect of azelastine on the release and action of leukotriene C4 and D4. Int Arch Allergy Appl Immunol 83:284–289, 1987Google Scholar
  23. 23.
    Tomioka H, Yoshida S, Tanaka M, Kumagai A: Inhibition of chemical mediator release from human leukocytes by a new antiasthma drug (ketotifen). Monogr Allergy 14:313–317, 1979Google Scholar
  24. 24.
    Lue SL, Paronetto F, Lieber CS: Cytotoxicity of mononuclear cells and vulnerability of hepatocytes in alcoholic fatty liver of baboons. Liver 1:264–267, 1981Google Scholar
  25. 25.
    Mavier P, Preaux AM, Guigui B, Lescs MC, Zafrani ES, Dhumeaux D:In vitro toxicity of polymorphonuclear neutrophils to rat hepatocytes: Evidence for a proteinase-mediated mechanism. Hepatology 8:254–258, 1988Google Scholar
  26. 26.
    Weiner FR, Czaja MJ, Zern MA: Ethanol and the liver.In The Liver: Biology and Pathobiology. IM Arias, WB Jakoby, H Popper, D Schachter, DA Shafritz (eds). New York, Raven press, 1988, pp. 1169–1193Google Scholar
  27. 27.
    Peters M, Liebman HA, Tong MJ, Tinberg HM: Alcoholic hepatitis: Granulocyte chemotactic factor from Mallory body-stimulated human peripheral blood mononuclear cells. Clin Immunol Immunopathol 28:418–430, 1983Google Scholar
  28. 28.
    Tanner A, Keyhani A, Reiner R, Holdstock G, Wright R: Proteolytic enzymes released by liver macrophages may promote hepatic injury in a rat model of hepatic damage. Gastroenterology 80:647–654, 1981Google Scholar
  29. 29.
    Arthur MJP, Kowalski-Saunders P, Wright R:Corynebacterium parvum elicited hepatic macrophages demonstrate enhanced respiratory burst activity compared with resident Kupffer cells in rats. Gastroenterology 91:174–181, 1986Google Scholar
  30. 30.
    Maddrey WC: Alcoholic hepatitis: Clinicopathologic features and therapy. Semin Liver Dis 8:91–102, 1988Google Scholar
  31. 31.
    Depew W, Boyer T, Omata M, Redeker A, Reynolds T: Double blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy. Gastroenterology 78:524–529, 1980Google Scholar
  32. 32.
    Mendenhall CL, Anderson S, Gaicia-Pont P, Goldberg S, Kierman T, Seeff LB, Sorrell M, Tamburro C, Weesner R, Zetterman R, Chedid A, Chen T, Rubin L: Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med 311:1464–1470, 1984Google Scholar
  33. 33.
    Klebanoff SJ: Oxygen metabolism and the toxic properties of phagocytes. Ann Intern Med 93:480–489, 1980Google Scholar
  34. 34.
    Fantone JC, Ward PA: Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol 107:397–418, 1982Google Scholar
  35. 35.
    Chand N, Pillar J, Diamantis W, Sofia RD: Inhibition of allergic histamine release by azelastine and selected antiallergic drugs from rabbit leukocytes. Int Arch Allergy Appl Immunol 77:451–455, 1985Google Scholar
  36. 36.
    Takahashi S, Nagano S: E-0659: Phase I test. Tokyo; Eisai Co. Research Report, 1976, pp 1–53 (in Japanese)Google Scholar
  37. 37.
    Kennedy GR: Metabolism and pharmacokinetics of ketotifen in children. Res Clin Forum 4:17–20, 1982Google Scholar

Copyright information

© Plenum Publishing Corporation 1994

Authors and Affiliations

  • Yasushi Shiratori
    • 1
    • 3
    • 2
  • Hiroshi Takada
    • 1
    • 3
    • 2
  • Kenji Hai
    • 1
    • 3
    • 2
  • Hiroki Kiriyama
    • 1
    • 3
    • 2
  • Emmanuel Mawet
    • 1
    • 3
    • 2
  • Yutaka Komatsu
    • 1
    • 3
    • 2
  • Yasuro Niwa
    • 1
    • 3
    • 2
  • Masayuki Matsumura
    • 1
    • 3
    • 2
  • Shuichiro Shiina
    • 1
    • 3
    • 2
  • Tateo Kawase
    • 1
    • 3
    • 2
  • Kazunori Matsumoto
    • 1
    • 3
    • 2
  • Kazuo Kamii
    • 1
    • 3
    • 2
  • Masao Omata
    • 1
    • 3
    • 2
  • Mitsugu Tanaka
    • 1
    • 3
    • 2
  1. 1.From the Department of Gastroenterology and Hepatology, Koshigaya HospitalDokkyo University School of MedicineKoshigaya, SaitamaJapan
  2. 2.Department of PathologyJikei University School of MedicineTokyoJapan
  3. 3.Department of Internal Medicine (II)Faculty of Medicine, University of TokyoTokyoJapan

Personalised recommendations